Review article: Bone density in patients with chronic kidney disease stages 4-5

Area of Science:

• Nephrology
• Orthopedics
• Endocrinology

Background:

• Skeletal fractures are a significant complication for patients undergoing dialysis.
• Traditional bone density measurements, effective in the general population, show limited predictive value for fractures in chronic kidney disease (CKD) patients.

Purpose of the Study:

• To review the literature on the utility of bone density measurements in predicting fractures and assessing bone health in patients with CKD stage 5.
• To evaluate the relationship between bone density, serum parathyroid hormone (PTH) levels, and underlying bone histology in this population.

Main Methods:

• Literature review of studies involving patients with CKD stage 5.
• Analysis of bone density data from cortical bone (radius, hip) and spine.
• Examination of the correlation between serum PTH levels and bone density.

Main Results:

• Bone density in the radius and hip is generally lower (1-2 SDs) in CKD stage 5 patients compared to reference ranges, while spinal bone density is closer to average.
• Bone density measurements cannot predict the specific histology of renal osteodystrophy.
• Serum PTH levels show inconsistent or no association with bone density, with no studies finding a positive correlation.

Conclusions:

• The clinical utility of bone density measurements in CKD stage 5 patients remains uncertain due to limitations in fracture prediction and inability to guide histological assessment.
• Further research is needed on longitudinal bone density changes and the efficacy of osteoporosis medications in this patient group.